Nuclear medicine for imaging of epithelial ovarian cancer. (May 2016)

• Record Type: Journal Article
• Authors: Abedi, Seyed Mohammad; Mardanshahi, Alireza; Shahhosseini, Roza; Hosseinimehr, Seyed Jalal
• Is Part Of: Future oncology. Volume 12:Number 9(2016)
• Page Start: 1165
• Page End: 1177
• Publication Date: 2016-05
• Subjects: diagnosis -- epithelial ovarian cancer -- imaging -- nuclear medicine -- radiopharmaceutical; Oncology -- Periodicals; 616.99405
• DOI: 10.2217/fon.16.19
• Languages: English
• ISSNs: 1479-6694

Abstract

Cancer is one of the leading causes of mortality worldwide. Usually, the diagnosis of cancer at an early stage is important to facilitate proper treatment and survival. Nuclear medicine has been successfully used in the diagnosis, staging, therapy and monitoring of cancers. Single-photon emission computed tomography and PET-based companion imaging agents are in development for use as a companion diagnostic tool for patients with ovarian cancer. The present review discusses the basic and clinical studies related to the use of radiopharmaceuticals in the diagnosis and management of ovarian cancer, focusing on their utility and comparing them with other imaging techniques such as computed tomography and MRI.